[MigVax in Israel21C] In the race for a coronavirus vaccine, first doesn’t mean best

However, vaccine development, like drug development, is a long and complicated process. And it doesn’t always succeed, explains industry expert Ron Ellis, editor in chief of Human Vaccines & Immunotherapeutics and a consultant for Israeli vaccine development company MigVax.

Read more here.

The post [MigVax in Israel21C] In the race for a coronavirus vaccine, first doesn’t mean best appeared first on OurCrowd.

OurCrowd

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *